Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...

A significant link was found between active cigarette smoking and an elevated rate of pneumonia in COPD, whereas this was not ...

Adding sotatercept to standard therapy within a year of diagnosis lowers the risk for clinical worsening in patients with ...

Savara Inc. (NASDAQ:SVRA) is a clinical-stage biopharmaceutical company focused on developing therapies for rare respiratory ...

Discover why Regeneron Pharmaceuticals, Inc.'s Q3 earnings impress, fueled by Dupixent growth and a robust pipeline. Click ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced plans to present new research from ...

GSK plc ( GSK) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Ladies and gentlemen, a very warm welcome to the GSK Q3 2025 Results Call. I'm delighted to be joined today by Emma Walmsley, Luke ...

Avalyn will present four posters in conjunction with the PFF Summit 2025 Welcome Reception from 5-8 p.m. CT on Thursday, November 13, 2025.

The news on vaccines was not so good, as declining sales of shingles shot Shingrix in the US and China pegged back growth to ...

On October 27, 2025, Merck announced that the FDA approved an expanded label for WINREVAIR (sotatercept-csrk), allowing its ...

The study found that the use of the company’s computer-assisted vacuum thrombectomy (CAVT) system, a form of mechanical ...

Penumbra Inc.’s 'resoundingly positive' results from its STORM-PE trial could see current guidelines for anticoagulant use in ...